Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Clinical trial NCT01393613 · COMPLETED
Trial details
- NCT number
- NCT01393613
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-02-01
- Enrollment
- 674
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.